Hualan Biological Engineering Metrics - aVenture Research
Metrics
Revenue Estimate
$660M
Period: 1 yearAs of
Revenue Growth Estimate
6%
Period: 1 yearAs of
Earnings per Share
$0.08
As of
EBIT Growth
-1%
Period: 1 yearAs of
EBIT Margin
27%
Period: 1 yearAs of
EBITDA
$218M
Period: 1 yearAs of
EBITDA Growth
-9%
Period: 1 yearAs of
EBITDA Margin
33%
Period: 1 yearAs of
Enterprise Value
$3.2B
As of
EV/EBIT
17.6x
Period: 1 yearAs of
EV/EBITDA
14.6x
Period: 1 yearAs of
EV/FCF
4.3x
Period: 1 yearAs of
EV/Gross Profit
9.1x
Period: 1 yearAs of
EV/Revenue
4.8x
Period: 1 yearAs of
FCF Growth
-14%
Period: 1 yearAs of
FCF Margin
15%
Period: 1 yearAs of
G&A Expenses to Revenue
5%
Period: 1 yearAs of
Gross Margin
53%
Period: 1 yearAs of
Gross Profit
$349M
Period: 1 yearAs of
Gross Profit Growth
-1%
Period: 1 yearAs of
Market Capitalization
$3.3B
As of
Net Income
$132M
Period: 1 yearAs of
Net Income Growth
-13%
Period: 1 yearAs of
Net Margin
20%
Period: 1 yearAs of
Opex to Revenue
31%
Period: 1 yearAs of
P/E
25.3x
Period: 1 yearAs of
R&D Expenses to Revenue
7%
Period: 1 yearAs of
Rule of 40
42%
Period: 1 yearAs of
Rule of X
55%
Period: 1 yearAs of
S&M Expenses to Revenue
18%
Period: 1 yearAs of
Share Price Change
-17.1%
Period: 12 monthsAs of
Hualan Biological Engineering
Hualan Biological Engineering is a biotechnology company that researches, develops, produces, and sells blood products, vaccines, and recombinant proteins.